Skip to content

Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression

Yoga, Health, and Meditation

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00090506
Enrollment
50
Registered
2004-08-27
Start date
2004-07-31
Completion date
2007-03-31
Last updated
2008-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Diabetes, HIV Infections

Keywords

Yoga, Meditation

Brief summary

The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.

Detailed description

In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations. Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.

Interventions

BEHAVIORALYoga

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
Lead SponsorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

for Study 1 Participants: * Meet certain laboratory requirements Inclusion Criteria for Study 2 Participants: * HIV infected * Able to walk at least 50% of the time Inclusion Criteria for All Participants: * Written informed consent of parent/guardian, if applicable

Exclusion criteria

for Study 2 Participants: * Require antiretroviral therapy

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026